Retraction notice to "Allele-specific in situ analysis of microchimerism by fluorescence resonance energy transfer (FRET) in nonhuman primate tissues" [Hum Immunol (2002) 108 - 120] (PII:S0198-8859(01)00364-0);Allele-specific in situ analysis of microchimerism by fluorescence resonance energy transfer (FRET) in nonhuman primate tissues

Human Immunology

Volumn 63, Issue 2, 2002, Pages 108-120

  Lobashevsky, A L ^a   Jiang, X L ^a   Thomas, J M ^a  

^a Kentucky   (United States)

Author keywords

FRET; Hybridization; Kidney transplantation; Microchimerism; Nonhuman primates

Indexed keywords

15 DEOXYSPERGUALIN; CD3 ANTIGEN; CD34 ANTIGEN; CD8 ANTIGEN; DIPHTHERIA TOXIN; IMMUNOTOXIN; MESSENGER RNA; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY;

ALLELE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHIMERA; ENERGY TRANSFER; FLUORESCENCE; FLUORESCENCE RESONANCE ENERGY TRANSFER; IMMUNOHISTOCHEMISTRY; KIDNEY TRANSPLANTATION; NONHUMAN; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIMATE; PRIORITY JOURNAL;

EID: 0036166560     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.11.001     Document Type: Erratum

References (51)

1. Preclinical bridge to clinical tolerance
2. Transplantation tolerance: A look at the nonhuman primate literature in the light of modern tolerance theories
3. Status of microchimerism in recipients 15 years after living related kidney transplantation
4. Mixed chimerism and transplantation tolerance
5. Strategies for induction of clinical tolerance
6. Use of donor-specific bone marrow to facilitate tolerance in clinical solid organ transplantation: Old facts and future prospects
7. Promotion of incompatible allograft acceptance in rhesus monkeys given posttransplant antithymocyte globulin and donor bone marrow. I. In vivo parameters and immunohistologic evidence suggesting microchimerism
8. Cell migration, chimerism, and graft acceptance
9. Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients
10. Six-year clinical effect of donor bone marrow infusions in renal transplant patients
11. Kidney transplantation with bone marrow augmentation: Five-year outcomes
12. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys
13. Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism
14. Preclinical studies of allograft tolerance in rhesus monkeys: A novel anti-CD3-immunotoxin given peritransplant with donor bone marrow induces operational tolerance to kidney allografts
15. Bone marrow-derived chimerism in non-irradiated, cyclosporin-treated rats receiving microvascularized limb transplants: Evidence for dono-derived dendritic cells in recipient lymphoid tissues
16. Tolerance to vascularized organ allografts in large-animal models
17. Systemic chimerism in sex-mismatched liver transplant recipients detected by fluorescence in situ hybridization
18. Assessment of donor bone marrow cell-derived chimerism in transplantation tolerance using transgenic mice
19. An assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry
20. Peripheral blood chimerism in renal allograft recipients transfused with donor bone marrow
21. Correlation of donor antigen-specific hyporeactivity with allogeneic microchimerism in kidney and lung recipients
22. Role of the graft as a source of donor-type microchimerism in liver transplant patients
23. Donor-type chimerism determination by competitive polymerase chain reaction (PCR) in a primate model for bone marrow transplantation
24. Durable donor-specific T and B cell tolerance in rhesus maques induced with peritransplantatio anti-CD3 immunotoxin and deoxyspergualin
25. Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation
26. Fluorescent indicators for Ca2+ based on green fluorescent proteins and calmodulin
27. Direct observation of specific messenger RNA in a single living cell under a fluorescence microscope
28. Peritransplant tolerance induction with anti-CD3-immunotoxin: A matter of proinflammatory cytokine control
29. Identification of DRB alleles in rhesus monkeys using polymerase chain reaction-sequence-specific primers (PCR-SSP) amplification
30. Six mamu-A locus alleles defined by a polymerase chain reaction sequence specific primer method
31. Estimation of cellular DNA content in cell lysates suitable for RNA isolation
32. Digoxigenin as an alternative probe labeling for in situ hybridization
33. Comparison of 35S- and digoxigenin-labeled RNA and oligonucleotide probes for in situ hybridization. Expression of mRNA of the seminal vesicle secretion protein II and androgen receptor genes in the rat prostate
34. Chimerism after organ transplantation
35. Is chimerism necessary for tolerance and how?
36. Peritransplant tolerance induction in macaques: Early events reflecting the unique synergy between immunotoxin and deoxyspergualin
37. Detection of donor-derived cells by polymerase chain reaction in neonatally tolerant mice. Microchimerism fails to predict tolerance
38. Peripheral blood microchimerism in human liver and renal transplant recipients: Rejection despite donor-specific chimerism
39. Donor-recipient microchimerism is not required for tolerance induction following recipient pretreatment with donor-specific transfusion and anti-CD4 antibody. Evidence of a clear role for short-term antigen persistence
40. Induction of long-term graft tolerance and donor/recipient chimerism
41. Allogeneic lymphocyte chimerism after clinical lung transplantation
42. The functional relevance of passenger leukocytes and microchimerism for heart allograft acceptance in the rat
43. Allogeneic hematolymphoid microchimerism and prevention of autoimmune disease in the rat. A relationship between allo- and autoimmunity
44. Microchimerism and rejection in clinical transplantation
45. An examination of tissue chimerism in the ACI to Lewis rat cardiac transplant model
46. Peripheral microchimerism in long-term cadaveric-kidney allograft recipients
47. Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance
48. Microchimerism frequency two to thirty years after cadaveric kidney transplantation
49. Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy
50. Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease
51. T-lymphocyte production of macrophage inflammatory protein-1alpha is critical to the recruitment of CD8(+) T cells to the liver, lung, and spleen during graft-versus-host disease